The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor
Open accessAbstract
Replacement of the central, para-substituted fluorophenyl ring in the γ-secretase inhibitor 1 (BMS-708,163) with the bicyclo[1.1.1]pentane motif led to the discovery of compound 3, an equipotent enzyme inhibitor with significant improvements in passive permeability and aqueous solubility. The modified biopharmaceutical properties of 3 translated into excellent oral absorption characteristics (~4-fold ↑ C(max) and AUC values relative to 1) in a mouse model of γ-secretase inhibition. In addition, SAR studies into other fluorophenyl replacements indicate the intrinsic advantages of the bicyclo[1.1.1]pentane moiety over conventional phenyl ring replacements with respect to achieving an optimal balance of properties (e.g., γ-secretase inhibition, aqueous solubility/permeability, in vitro metabolic stability). Overall, this work enhances the scope of the [1.1.1]-bicycle beyond that of a mere "spacer" unit and presents a compelling case for its broader application as a phenyl group replacement in scenarios where the aromatic ring count impacts physicochemical parameters and overall drug-likeness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Lovering, F., Bikker, J., & Humblet, C. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901241e · Cited by 4,495
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Meanwell, N. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013693 · Cited by 2,854
Bioisosterism: A Rational Approach in Drug Design
Patani, G. A., & LaVoie, E. J. (1996) · Chemical Reviews · doi:10.1021/cr950066q · Cited by 1,328
Wager, T. T., Hou, X., Verhoest, P. R., & Villalobos, A. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100008c · Cited by 1,063
Ritchie, T. J., & Macdonald, S. J. F. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.07.014 · Cited by 901
γ-Secretase: proteasome of the membrane?
Kopan, R., & Ilagan, M. X. G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1406 · Cited by 554
Wager, T. T., Chandrasekaran, R. Y., Hou, X., Troutman, M. D., Verhoest, P. R., Villalobos, A., & Will, Y. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100007x · Cited by 477
Cellular mechanisms of β-amyloid production and secretion
Sinha, S., & Lieberburg, I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11049 · Cited by 437
Selkoe, D. J. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004457 · Cited by 363
ElogDoct: A Tool for Lipophilicity Determination in Drug Discovery. 2. Basic and Neutral Compounds
Lombardo, F., Shalaeva, M. Y., Tupper, K. A., & Gao, F. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0100990 · Cited by 307
Hosea, N. A., Collard, W. T., Cole, S., Maurer, T. S., Fang, R. X., Jones, H., Kakar, S. M., Nakai, Y., Smith, B. J., Webster, R., et al. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009333209 · Cited by 300
Substrate specificity of γ-secretase and other intramembrane proteases
Beel, A. J., & Sanders, C. R. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7462-2 · Cited by 269
Pellicciari, R., Raimondo, M., Marinozzi, M., Natalini, B., Costantino, G., & Thomsen, C. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960254o · Cited by 202
Gillman, K. W., Starrett, J. E., Parker, M. F., Xie, K., Bronson, J. J., Marcin, L. R., McElhone, K. E., Bergstrom, C. P., Mate, R. A., Williams, R., et al. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml1000239 · Cited by 185
Callegari, E., Malhotra, B., Bungay, P. J., Webster, R., Fenner, K. S., Kempshall, S., LaPerle, J. L., Michel, M. C., & Kay, G. G. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.03961.x · Cited by 179
γ-secretases: from cell biology to therapeutic strategies
Bergmans, B. A., & De Strooper, B. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70332-1 · Cited by 170
The γ-Secretase Complex: Membrane-Embedded Proteolytic Ensemble
Wolfe, M. S. (2006) · Biochemistry · doi:10.1021/bi060799c · Cited by 161
Kalgutkar, A. S. S., Vaz, A. D. N., Lame, M. E., Henne, K. R., Soglia, J. R., Zhao, S. X., Abramov, Y. A., Lombardo, F., Collin, C., Hendsch, Z. S., et al. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001735 · Cited by 155
Edwards, M. P., & Price, D. A. (2010) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(10)45023-x · Cited by 147
Acquired QT interval prolongation and HERG: implications for drug discovery and development
Finlayson, K., Witchel, H. J., McCulloch, J., & Sharkey, J. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.019 · Cited by 147
Stepan, A. F., Karki, K., McDonald, W. S., Dorff, P. H., Dutra, J. K., DiRico, K. J., Won, A. C., Subramanyam, C., Efremov, I. V., O’Donnell, C. J., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200893p · Cited by 109
Self-citationKreft, A. F., Martone, R. L., & Porte, A. M. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900188z · Cited by 107
The Amyloid-β Rise and γ-Secretase Inhibitor Potency Depend on the Level of Substrate Expression
Burton, C. R., Meredith, J. E., Barten, D. M., Goldstein, M. E., Krause, C., Kieras, C. J., Sisk, L. M., Iben, L. G., Polson, C. T., Thompson, M. W., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804175200 · Cited by 63
Zientek, M. A., Miller, H., Smith, D., Dunklee, M. B., Heinle, L. J., Thurston, A., Lee, C. G. L., Hyland, R., Fahmi, O. A., & Burdette, D. S. (2008) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2008.05.131 · Cited by 62
Pharmacodynamics and Pharmacokinetics of the γ-Secretase Inhibitor PF-3084014
Lanz, T. A., Wood, K. M., Richter, K. E. G., Nolan, C. E., Becker, S. L., Pozdnyakov, N., Martin, B., Du, P., Oborski, C., Wood, D. E., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.167379 · Cited by 50
Self-citationNovel γ-secretase modulators: a review of patents from 2008 to 2010
Pettersson, M., Kauffman, G. W., Ende, C. W. A., Patel, N. C., Stiff, C. M., Tran, T. P., & Johnson, D. S. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.547479 · Cited by 45
Self-citationBrodney, M. A., Auperin, D. D., Becker, S. L., Bronk, B. S., Brown, T. M., Coffman, K. J., Finley, J. E., Hicks, C. D., Karmilowicz, M. J., Lanz, T. A., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.12.118 · Cited by 35
Self-citationLu, Y., Zhang, L., Nolan, C. E., Becker, S. L., Atchison, K. P., Robshaw, A., Pustilnik, L. R., Osgood, S. M., Miller, E. H., Stepan, A. F., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.186791 · Cited by 25
Self-citationBrodney, M. A., Auperin, D. D., Becker, S. L., Bronk, B. S., Brown, T. M., Coffman, K. J., Finley, J. E., Hicks, C. D., Karmilowicz, M. J., Lanz, T. A., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.12.117 · Cited by 15
Self-citation
Cited by
Bioisosteres of the Phenyl Ring: Recent Strategic Applications in Lead Optimization and Drug Design
Subbaiah, M. A. M., & Meanwell, N. A. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01215 · Cited by 710
Bicyclobutanes: from curiosities to versatile reagents and covalent warheads
Kelly, C. B., Milligan, J. A., Tilley, L. J., & Sodano, T. M. (2022) · Chemical Science · doi:10.1039/d2sc03948f · Cited by 334
Aguilar, A., Lu, J., Liu, L., Du, D., Bernard, D., McEachern, D., Przybranowski, S., Li, X., Luo, R., Wen, B., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01665 · Cited by 211
Metadata
- Authors
- Stepan, A. F., Subramanyam, C., Efremov, I. V., Dutra, J. K., O’Sullivan, T. J., DiRico, K. J., McDonald, W. S., Won, A., Dorff, P. H., Nolan, C. E., Becker, S. L., Pustilnik, L. R., Riddell, D. R., Kauffman, G. W., Kormos, B. L., Zhang, L., Lu, Y., Capetta, S. H., Green, M. E., Karki, K., Sibley, E., Atchison, K. P., Hallgren, A. J., Oborski, C. E., Robshaw, A. E., Sneed, B., & O’Donnell, C. J.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2012-03-29
- Volume
- 55
- Issue
- 7
- Pages
- 3414-3424
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2100446581
- Cited by
- 468
- References
- 30
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.